The EGFR family and its ligands in human cancer. signalling mechanisms and therapeutic opportunities.
暂无分享,去创建一个
[1] W. McGuire,et al. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. , 1987, Science.
[2] Joseph Schlessinger,et al. Signal transduction by receptors with tyrosine kinase activity , 1990, Cell.
[3] Paul W. Sternberg,et al. The let-23 gene necessary for Caenorhabditis elegans vulval induction encodes a tyrosine kinase of the EGF receptor subfamily , 1990, Nature.
[4] Z. Kelman,et al. Transmembrane signalling receptors for cytokines and growth factors , 1991 .
[5] Paul W. Sternberg,et al. The gene lin-3 encodes an inductive signal for vulval development in C. elegans , 1992, Nature.
[6] W. Birchmeier,et al. Molecular aspects of mesenchymal-epithelial interactions. , 1993, Annual review of cell biology.
[7] David C. Lee,et al. TGFα deficiency results in hair follicle and eye abnormalities in targeted and waved-1 mice , 1993, Cell.
[8] E. Nice,et al. Mice with a null mutation of the TGFα gene have abnormal skin architecture, wavy hair, and curly whiskers and often develop corneal inflammation , 1993, Cell.
[9] E. Wagner,et al. Strain-dependent epithelial defects in mice lacking the EGF receptor. , 1995, Science.
[10] R. Derynck,et al. Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor , 1995, Nature.
[11] K. Herrup,et al. Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. , 1995, Science.
[12] Y. Yarden,et al. A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor , 1996, Molecular and cellular biology.
[13] Y. Yarden,et al. ErbB‐2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer. , 1996, The EMBO journal.
[14] B. Shilo,et al. A thousand and one roles for the Drosophila EGF receptor. , 1997, Trends in genetics : TIG.
[15] Y. Yarden,et al. Pathogenic poxviruses reveal viral strategies to exploit the ErbB signaling network , 1998, The EMBO journal.
[16] A. Lenferink,et al. Differential endocytic routing of homo‐ and hetero‐dimeric ErbB tyrosine kinases confers signaling superiority to receptor heterodimers , 1998, The EMBO journal.
[17] Z. Kam,et al. c-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor. , 1998, Genes & development.
[18] W. Miller,et al. The EGFR as a target for viral oncoproteins. , 1999, Trends in microbiology.
[19] A Ciechanover,et al. Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl/Sli-1. , 1999, Molecular cell.
[20] Z. Werb,et al. Signaling through the stromal epidermal growth factor receptor is necessary for mammary ductal development. , 1999, Development.
[21] Y. Yarden,et al. Tumor-inhibitory antibodies to HER-2/ErbB-2 may act by recruiting c-Cbl and enhancing ubiquitination of HER-2. , 2000, Cancer research.
[22] Y. Yarden,et al. Biochemical and clinical implications of the ErbB/HER signaling network of growth factor receptors. , 2000, Advances in cancer research.
[23] Y. Yarden,et al. Untangling the ErbB signalling network , 2001, Nature Reviews Molecular Cell Biology.